Salix Gets FDA Approval For Colazal in Pediatric UC Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Colazal becomes first 5-ASA approved for pediatric ulcerative colitis, firm says.
You may also be interested in...
Salix Expects Two NDA Submissions In Fourth Quarter For Gastrointestinal Indications
Firm’s granulated mesalamine is in development for ulcerative colitis, while its partner, Wilmington, plans to file metoclopramide-Zydis for gastroesphageal reflux.
Salix Expects Two NDA Submissions In Fourth Quarter For Gastrointestinal Indications
Firm’s granulated mesalamine is in development for ulcerative colitis, while its partner, Wilmington, plans to file metoclopramide-Zydis for gastroesphageal reflux.
Shire's Lialda Launch For Ulcerative Colitis Will Focus On Dosing Convenience
Shire is planning an sNDA for a remission maintenance claim within two years, the firm tells "The Pink Sheet" DAILY.